Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
08 05 2023
Historique:
medline: 9 5 2023
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations. In the present work, we setup and applied two distinct metadynamics protocols to estimate the RTs of muscarinic M3 receptor antagonists. In the first method, derived from the conformational flooding approach, the kinetics of unbinding is retrieved from a physics-based parameter known as the acceleration factor α (i.e., the running average over time of the potential deposited in the bound state). Such an approach is expected to recover the absolute RT value for a compound of interest. In the second method, known as the

Identifiants

pubmed: 37053454
doi: 10.1021/acs.jcim.3c00042
pmc: PMC10170513
doi:

Substances chimiques

Receptor, Muscarinic M3 0
Ligands 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2842-2856

Références

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12046-12050
pubmed: 30404914
J Chem Theory Comput. 2021 Oct 12;17(10):6610-6623
pubmed: 34495672
J Chem Inf Model. 2022 Jan 10;62(1):210-222
pubmed: 34932329
J Med Chem. 2016 May 12;59(9):4035-61
pubmed: 26807648
Drug Discov Today. 2013 Jul;18(13-14):667-73
pubmed: 23454741
J Med Chem. 2011 Oct 13;54(19):6888-904
pubmed: 21870878
J Chem Inf Model. 2015 Sep 28;55(9):1857-66
pubmed: 26335976
Q Rev Biophys. 2015 Nov;48(4):479-87
pubmed: 26537408
Bioorg Med Chem Lett. 2015;25(10):2019-27
pubmed: 25782745
Biochem Pharmacol. 2016 Apr 1;105:34-41
pubmed: 26930564
J Am Chem Soc. 2017 Apr 5;139(13):4780-4788
pubmed: 28290199
Chem Rev. 2020 Dec 9;120(23):12788-12833
pubmed: 33006893
J Mol Graph Model. 2010 Sep;29(2):157-70
pubmed: 20579912
Methods Mol Biol. 2018;1824:287-298
pubmed: 30039414
Med Res Rev. 2014 Jul;34(4):856-92
pubmed: 24549504
J Chem Phys. 2007 Feb 7;126(5):054103
pubmed: 17302470
Structure. 2014 Nov 4;22(11):1657-64
pubmed: 25450769
Br J Pharmacol. 2019 Aug;176(16):2864-2876
pubmed: 31077341
Mol Pharmacol. 2009 Sep;76(3):543-51
pubmed: 19498041
J Chem Phys. 2004 Jun 22;120(24):11919-29
pubmed: 15268227
J Chem Inf Model. 2020 Nov 23;60(11):5340-5352
pubmed: 32315175
Nat Rev Drug Discov. 2016 Feb;15(2):87-95
pubmed: 26678621
J Chem Theory Comput. 2021 Jul 13;17(7):4291-4300
pubmed: 34096718
J Chem Theory Comput. 2019 May 14;15(5):3354-3361
pubmed: 30913388
J Chem Theory Comput. 2019 May 14;15(5):3316-3330
pubmed: 30893556
Curr Opin Chem Biol. 2010 Aug;14(4):467-74
pubmed: 20663707
Sci Rep. 2015 Jun 23;5:11539
pubmed: 26103621
Comput Struct Biotechnol J. 2014 Dec 10;13:111-21
pubmed: 25709761
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Biopolymers. 1992 May;32(5):523-35
pubmed: 1515543
Expert Opin Drug Discov. 2010 Nov;5(11):1023-9
pubmed: 22827742
J Chem Theory Comput. 2018 Jul 10;14(7):3859-3869
pubmed: 29768913
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1995 Sep;52(3):2893-2906
pubmed: 9963736
J Med Chem. 2007 Apr 5;50(7):1693-7
pubmed: 17352463
J Chem Theory Comput. 2014 Apr 8;10(4):1420-5
pubmed: 26580360
Chemistry. 2016 Jun 6;22(24):8048-52
pubmed: 27139720
J Med Chem. 2013 Nov 14;56(21):8746-56
pubmed: 24088171
Nature. 2012 Feb 22;482(7386):552-6
pubmed: 22358844
J Am Chem Soc. 2012 Jan 11;134(1):453-63
pubmed: 22092197
Life Sci. 1999;64(6-7):457-64
pubmed: 10069510
J Med Chem. 2022 Aug 11;65(15):10233-10250
pubmed: 35901125
Life Sci. 1993;52(5-6):537-44
pubmed: 8441333
Nucleic Acids Res. 2012 Jan;40(Database issue):D71-5
pubmed: 22102590
Drug Discov Today. 2013 Aug;18(15-16):697-707
pubmed: 23500610
J Chem Inf Model. 2023 Feb 27;63(4):1301-1312
pubmed: 36762429
J Med Chem. 2007 Apr 5;50(7):1571-83
pubmed: 17352462
J Med Chem. 2017 Jan 26;60(2):787-796
pubmed: 28005388
J Chem Inf Model. 2017 Feb 27;57(2):159-169
pubmed: 28080056
Front Mol Biosci. 2022 Jun 08;9:899805
pubmed: 35755817
Phys Rev Lett. 2008 Jan 18;100(2):020603
pubmed: 18232845
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E386-91
pubmed: 25605901
J Chem Inf Model. 2020 Mar 23;60(3):1804-1817
pubmed: 32126172
Sci Rep. 2016 Aug 08;6:31046
pubmed: 27499063
J Med Chem. 2021 Jul 8;64(13):9100-9119
pubmed: 34142835
J Chem Theory Comput. 2019 Aug 13;15(8):4646-4659
pubmed: 31246463
Phys Rev Lett. 2013 Dec 6;111(23):230602
pubmed: 24476246
Acc Chem Res. 2015 Feb 17;48(2):277-85
pubmed: 25496113
J Chem Inf Model. 2017 Aug 28;57(8):1895-1906
pubmed: 28749138
J Phys Chem Lett. 2020 Aug 6;11(15):6373-6381
pubmed: 32672983
J Chem Inf Model. 2010 May 24;50(5):771-84
pubmed: 20450209
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15414-15422
pubmed: 32571939
Chest. 2000 Feb;117(2 Suppl):63S-6S
pubmed: 10673478

Auteurs

Francesca Galvani (F)

Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.

Daniele Pala (D)

Chemistry Research and Drug Design Department, Chiesi Farmaceutici S.p.A., Largo F. Belloli 11/A, 43122 Parma, Italy.

Alberto Cuzzolin (A)

Chemistry Research and Drug Design Department, Chiesi Farmaceutici S.p.A., Largo F. Belloli 11/A, 43122 Parma, Italy.

Laura Scalvini (L)

Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.

Alessio Lodola (A)

Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.

Marco Mor (M)

Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.
Microbiome Research Hub, University of Parma, Parco Area delle Scienze 11/A, I-43124 Parma, Italy.

Andrea Rizzi (A)

Chemistry Research and Drug Design Department, Chiesi Farmaceutici S.p.A., Largo F. Belloli 11/A, 43122 Parma, Italy.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils.

Philipp Huettemann, Pavithra Mahadevan, Justine Lempart et al.
1.00
Polyphosphates alpha-Synuclein Humans Amyloid Molecular Dynamics Simulation

Classifications MeSH